Lichao Yang

1.3k total citations
50 papers, 1.0k citations indexed

About

Lichao Yang is a scholar working on Molecular Biology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lichao Yang has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Neurology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lichao Yang's work include Peroxisome Proliferator-Activated Receptors (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (13 papers) and Neurological Disease Mechanisms and Treatments (9 papers). Lichao Yang is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (13 papers) and Neurological Disease Mechanisms and Treatments (9 papers). Lichao Yang collaborates with scholars based in China and United States. Lichao Yang's co-authors include Peng Lu, Xin Jin, Yun Zhao, San‐Gang Wu, Tong Ren, Xin Jin, Wushuang Yang, Han Guo, Zhen‐Yu He and Jiayuan Sun and has published in prestigious journals such as PLoS ONE, Biomaterials and Analytical Chemistry.

In The Last Decade

Lichao Yang

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lichao Yang China 21 393 209 147 123 113 50 1.0k
Hailong Yu China 21 652 1.7× 228 1.1× 94 0.6× 123 1.0× 114 1.0× 58 1.3k
Qin Yin China 20 435 1.1× 151 0.7× 76 0.5× 214 1.7× 106 0.9× 56 1.1k
Cheng Peng China 17 459 1.2× 170 0.8× 113 0.8× 80 0.7× 121 1.1× 40 976
Chen-Yu Wang Taiwan 12 436 1.1× 249 1.2× 72 0.5× 158 1.3× 187 1.7× 20 1.1k
Sung‐Vin Yim South Korea 22 522 1.3× 124 0.6× 158 1.1× 147 1.2× 117 1.0× 61 1.3k
Kar‐Lok Wong Taiwan 20 463 1.2× 103 0.5× 98 0.7× 119 1.0× 105 0.9× 53 1.0k
Min Ji Choi South Korea 23 585 1.5× 104 0.5× 120 0.8× 160 1.3× 78 0.7× 91 1.6k

Countries citing papers authored by Lichao Yang

Since Specialization
Citations

This map shows the geographic impact of Lichao Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lichao Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lichao Yang more than expected).

Fields of papers citing papers by Lichao Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lichao Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lichao Yang. The network helps show where Lichao Yang may publish in the future.

Co-authorship network of co-authors of Lichao Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lichao Yang. A scholar is included among the top collaborators of Lichao Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lichao Yang. Lichao Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Xiaofeng, Ying Li, Jin Hao, et al.. (2025). Metformin-induced precise targeted inhibition of ischemic neuronal death by a programable endogenous ROS-responsive nanoprodrug. Chemical Engineering Journal. 512. 162106–162106.
2.
Li, Ying, Chuang Wu, Yanan Zhang, et al.. (2025). Oleoylethanolamide exerts neuroprotection following ischemic stroke through microglial PPARα signal. International Immunopharmacology. 158. 114824–114824.
3.
Gao, Fei, Weiping Lin, Tingting Zhao, et al.. (2025). Spatiotemporally controlled imaging of lysosomal pH via NIR/pH dual-activatable DNA nanomachines for early Alzheimer's disease detection. Sensors and Actuators B Chemical. 444. 138389–138389.
4.
Sun, Na, et al.. (2024). Intrinsic Capacity, Polygenic Risk Score, APOE Genotype, and Risk of Dementia. Neurology. 102(12). e209452–e209452. 6 indexed citations
5.
Fan, Zhongxiong, Xiaofeng Tan, Ying Li, et al.. (2023). ROS-responsive hierarchical targeting vehicle-free nanodrugs for three-pronged Parkinson’s disease therapy. Chemical Engineering Journal. 466. 143245–143245. 11 indexed citations
6.
Li, Ying, et al.. (2023). Oleoylethanolamide Protects against Acute Ischemic Stroke by Promoting PPARα-Mediated Microglia/Macrophage M2 Polarization. Pharmaceuticals. 16(4). 621–621. 16 indexed citations
7.
Fan, Zhongxiong, Tong Ren, Youjun Wang, et al.. (2022). Aβ-responsive metformin-based supramolecular synergistic nanodrugs for Alzheimer's disease via enhancing microglial Aβ clearance. Biomaterials. 283. 121452–121452. 32 indexed citations
8.
Fan, Zhongxiong, Wenbao Zuo, Dongtao Ge, et al.. (2022). Trojan-Horse Diameter-Reducible Nanotheranostics for Macroscopic/Microscopic Imaging-Monitored Chemo-Antiangiogenic Therapy. ACS Applied Materials & Interfaces. 14(4). 5033–5052. 9 indexed citations
9.
Wu, San‐Gang, Jian Lei, Hua Li, et al.. (2021). circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade. Cancer Cell International. 21(1). 277–277. 18 indexed citations
10.
Zhuo, Rengong, Yun Zhao, Lichao Yang, et al.. (2020). Oleoylethanolamide stabilizes atherosclerotic plaque through regulating macrophage polarization via AMPK-PPARα pathway. Biochemical and Biophysical Research Communications. 524(2). 308–316. 19 indexed citations
11.
Zhou, Juan, Weirong Chen, Lichao Yang, et al.. (2018). KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer. Cancer Research and Treatment. 51(3). 1207–1221. 55 indexed citations
12.
Zhao, Yun, Yijun Liu, Peng Lu, et al.. (2018). N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway. Biochemical and Biophysical Research Communications. 496(2). 415–421. 13 indexed citations
13.
Zhou, Juan, Wushuang Yang, Daqin Suo, et al.. (2018). Moringa oleifera Seed Extract Alleviates Scopolamine-Induced Learning and Memory Impairment in Mice. Frontiers in Pharmacology. 9. 389–389. 43 indexed citations
14.
Ren, Tong, et al.. (2018). Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5’monophosph kinase. Biomedicine & Pharmacotherapy. 103. 1384–1391. 20 indexed citations
15.
Lu, Peng, Xuefeng Huang, Xin Jin, et al.. (2017). Wedelolactone, a plant coumarin, prevents vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia through Akt and AMPK signaling. Experimental Gerontology. 96. 73–81. 13 indexed citations
16.
Zhou, Hao, Wushuang Yang, Ying Li, et al.. (2016). Oleoylethanolamide attenuates apoptosis by inhibiting the TLR4/NF-κB and ERK1/2 signaling pathways in mice with acute ischemic stroke. Naunyn-Schmiedeberg s Archives of Pharmacology. 390(1). 77–84. 34 indexed citations
17.
Zhao, Yun, Yan Lu, Xiumei Luo, et al.. (2016). A novel PPARα agonist propane-2-sulfonic acid octadec-9-enyl-amide inhibits inflammation in THP-1 cells. European Journal of Pharmacology. 788. 104–112. 12 indexed citations
18.
Yang, Lichao, Han Guo, Hao Zhou, et al.. (2015). Chronic oleoylethanolamide treatment improves spatial cognitive deficits through enhancing hippocampal neurogenesis after transient focal cerebral ischemia. Biochemical Pharmacology. 94(4). 270–281. 50 indexed citations
19.
Zhou, Juan, et al.. (2015). Prognostic Impact of ABO Blood Group on the Survival in Patients with Ovarian Cancer. Journal of Cancer. 6(10). 970–975. 16 indexed citations
20.
Zhou, Yu, Lichao Yang, Ang Ma, et al.. (2012). Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α. Neuropharmacology. 63(2). 242–249. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hailong Yu Breakdown of academic impact, for papers by Qin Yin Breakdown of academic impact, for papers by Cheng Peng Breakdown of academic impact, for papers by Chen-Yu Wang Breakdown of academic impact, for papers by Sung‐Vin Yim Breakdown of academic impact, for papers by Kar‐Lok Wong Breakdown of academic impact, for papers by Min Ji Choi
Rankless by CCL
2026